Day Care Surgery Centre Project Report: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue

Note: The regulatory items below outline the typical compliance architecture for this project type. Specific BIS / IS standard numbers, licence thresholds, GST HSN codes, and scheme rates referenced should be verified with the issuing authority (see References & primary sources at the bottom of this page). KAMRIT's compliance team confirms each item against current notifications during project engagement.

Day care surgery centre sits under India's strictest regulatory regime (CDSCO at the centre, state Drug Controllers, plus WHO-GMP and Schedule M). For ₹0.8 crore - ₹23 crore CapEx this DPR captures:

• NABL accreditation for QC lab, BSL-2/BSL-3 containment certification where applicable
• Bio-medical waste authorisation under BMW Rules 2016
• PLI Bulk Drugs (₹15,000 cr) or PLI Medical Devices (₹3,420 cr) participation
• NABH / NABL accreditation if the project includes a clinical or diagnostic arm
• Manufacturing licence under the Drugs and Cosmetics Act 1940 (Form 25/28/28A by category)

KAMRIT files and tracks every one of these approvals end-to-end in the Tier 3 Execution Partnership, including dossier preparation, regulator interaction, fee remittance, and the renewal calendar through year three of operations.

<p>The Indian ambulatory surgery sector is a structurally underserved and high-growth segment within the country's healthcare ecosystem. Daycare surgeries currently account for roughly 20% to 35% of the general surgery sub-specialty in India, indicating substantial headroom for expansion as awareness of outpatient surgical benefits grows among patients and payers. The sector is driven by a broad range of specialties, with orthopedics representing the largest revenue-generating segment as of 2025.

The Indian general surgical devices market itself reached USD 1.79 billion in 2025 and was valued at USD 2 billion in 2026, underpinning the equipment demand for new and expanding day care surgical facilities.</p><p>On the trade front, India's medical devices sector recorded import dependency historically ranging between 70% to 85%, though domestic greenfield investments are gradually reducing this reliance. During FY 2024 to 25, India imported approximately Rs 94,664 crore (approximately USD 11.4 billion) worth of medical devices and infrastructure sector products. On the export side, medical, surgical, and dental instruments and apparatus generated USD 1,417.31 million in 2024, representing 0.81% of total global exports and ranking India 20th worldwide.

The Production-Linked Incentive (PLI) Scheme has allocated INR 3,420 crore toward medical device manufacturing, with 23 greenfield plants commissioned, signaling a structural shift toward domestic supply chain resilience for surgical and day care infrastructure.</p><p>The broader healthcare supply chain in India faces significant inefficiencies, with the National Healthcare Supply Chain Council (NHSCC) noting that 40% of hospital supplies face delivery delays in tier-2 and tier-3 Indian cities, and estimated annual inventory wastage totaling Rs 12,000 Crore. Approximately 60% of Indian hospitals source their supplies through local distributors, highlighting an opportunity for vertically integrated day care surgery centre plants to optimize procurement and reduce operational waste.</p>

Project-specific demand drivers

• PLI Bulk Drug and Medical Devices
• US generics export opportunity
• Health insurance penetration rising
• Chronic disease burden growth
• Hospital capex expansion in Tier-2/3
• Telemedicine and digital health adoption

<p>Technology integration is a critical differentiator for modern Day Care Surgery Centre Plants, with significant advances in construction methodology, clinical workflow digitization, and operational efficiency reshaping the capital expenditure and operational cost profiles of new facilities. Modular offsite pre-manufacturing has emerged as a transformative approach, capable of reducing standard facility construction timelines from 24 months down to 12 months, as reported by MDN Development in 2025. This acceleration not only improves project economics but also enables faster revenue generation for investors.</p><p>Within clinical operations, integration of Advanced Case Management (ACM) digital platforms, artificial intelligence predictive algorithms, and cleanroom additive manufacturing systems such as 3D Systems technology are enabling higher throughput, lower complication rates, and better patient outcomes.

These technologies support real-time scheduling, predictive capacity management, and even patient-specific surgical planning. On the energy efficiency front, surgical and medical care facilities consume between 300 and 600 kWh per square meter annually, with HVAC systems accounting for 40% to 50% of total facility electricity consumption. LED lighting upgrades can reduce lighting electricity use by 50% to 70%, while standard operational temperature ranges of 20 degrees Celsius to 24 degrees Celsius and relative humidity norms of 30% to 60% must be maintained for optimal surgical and patient comfort conditions.</p><p>Capital expenditure for plant and property is a significant consideration.

The average gross plant, property, and equipment cost per operating room for multi-specialty ambulatory surgery centers is approximately USD 1.4 million, with the U.S. medical supply product sales to ASCs reaching nearly USD 2.7 billion in 2025. In India, domestic infrastructure manufacturers such as BPL Medical Technologies, with an established legacy in Indian medical technology focusing on patient monitoring and surgical support devices, and Aastha Meditec (Aastha Medical Technologies), with established infrastructure solutions and project experience, provide locally sourced alternatives to imported equipment, supporting the government's import substitution agenda.</p>

The means of finance for a day care surgery centre project should be structured to match the specific capex tier and catchment economics of the proposed facility. For a ₹3-6 crore project (4-8 beds, single OT), the recommended structure is: 30-35% promoter equity, 40-45% MSME term loan from scheduled commercial banks, 15-20% CGTMSE-backed working capital and equipment loan, and 5-10% from PMEGP grants where the entrepreneur qualifies under MSME Udyam registration. For a ₹8-15 crore project (12-20 beds, 2 OTs), the structure shifts to: 25-30% promoter equity, 45-50% term debt from a consortium of lenders, 10-15% from SIDBI healthcare-specific financing schemes offering 0.5-1.5% interest concession for Tier-2/3 location projects, and the remainder from state government MSME incentive grants and MNRE rooftop solar subsidy. HDFC Bank Healthcare Finance, ICICI Bank Healthcare Lending, Axis Bank Healthcare and SBC, and SBI Healthcare constitute the primary commercial lending relationships, all of which have dedicated healthcare verticals with faster approval turnaround. SIDBI's healthcare sector scheme and NABARD's credit facility for rural healthcare infrastructure are the most favourable term debt instruments for facilities located outside metropolitan cities. Working capital management is the most critical operational financial discipline: the insurance claims cycle of 45-90 days for cashless and reimbursement claims means a 60-90 day working capital cycle is standard. A ₹15-25 lakh working capital limit through an overdraft or current account CC limit from the primary lending bank is essential at commissioning. Insurance and government scheme revenue through CGHS, ECHS, Ayushman Bharat Pradhan Mantri Jan Arogya Yojana, and state government health schemes should be pursued actively as these provide 40-60% of patient volume in Tier-2 catchments and reduce debtor days to 30-45 against the private self-pay baseline of 60-90 days. The debt-equity ratio should not exceed 2.5:1 during the ramp-up phase (years 1-3) and should be restructured to 1.5:1 by year 4 as EBITDA cash generation covers capital expenditure. Interest coverage ratio targets of 1.8x during ramp-up and 2.5x at steady state are what lenders typically require for healthcare asset financing. Equipment leasing through Karnataka Bank Healthcare Finance and Bajaj Finserv Healthcare Equipment Finance can reduce upfront capex by 20-25% and preserve equity for working capital needs, particularly relevant for mid-tier projects where equipment constitutes 28-32% of total capex.

<p>Investors and operators in the Day Care Surgery Centre Plant segment face a range of structural and operational risks that warrant careful assessment. The most significant is margin volatility: the spread between top-decile EBITDA margins exceeding 40% and bottom-quartile margins below 15% demonstrates that operational excellence is not optional but essential. Factors driving this variance include labor costs, case mix quality, payer mix, supply chain efficiency, and utilization rates of expensive capital assets such as operating rooms.</p><p>Supply chain vulnerabilities represent a material ongoing risk.

The National Healthcare Supply Chain Council has documented that 40% of hospital supplies face delivery delays in tier-2 and tier-3 Indian cities, with estimated annual inventory wastage totaling Rs 12,000 Crore. Given India's historical import dependency of 70% to 85% for medical devices and surgical infrastructure, any disruption in global supply chains, currency fluctuations, or changes in import duty structures can significantly affect equipment availability and cost structures for day care surgery centre operators. While domestic manufacturing is growing under the PLI scheme, full import substitution remains a multi-year endeavor.</p><p>Energy and facilities management costs present another operational headwind.

Surgical and medical care facilities consume between 300 and 600 kWh per square meter annually, with HVAC loads alone representing 40% to 50% of total electricity consumption. In a market where energy prices remain volatile, these overheads can meaningfully compress margins if not managed through efficiency investments such as LED lighting upgrades (offering 50% to 70% lighting electricity reduction) and smart building management systems. Staffing risk is equally critical: the requirement for a 1:1 surgeon-to-patient, 1:1 anesthesiologist-to-patient, and 1:1 registered nurse-to-patient ratio means that any shortage of qualified medical professionals, particularly in tier-2 and tier-3 markets, can constrain facility throughput and revenue generation.

Regulatory compliance obligations, including the Clinical Establishments Act, fire safety certifications, bio-medical waste authorizations, and periodic license renewals, add ongoing administrative and cost burdens that must be factored into pro-forma projections.</p>